找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Endocrine Therapy of Breast Cancer IV; A. Goldhirsch Conference proceedings 1990 Springer-Verlag Berlin Heidelberg 1990 Hormonrezeptoren.O

[復制鏈接]
查看: 12009|回復: 47
樓主
發(fā)表于 2025-3-21 16:13:30 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Endocrine Therapy of Breast Cancer IV
編輯A. Goldhirsch
視頻videohttp://file.papertrans.cn/310/309738/309738.mp4
叢書名稱ESO Monographs
圖書封面Titlebook: Endocrine Therapy of Breast Cancer IV;  A. Goldhirsch Conference proceedings 1990 Springer-Verlag Berlin Heidelberg 1990 Hormonrezeptoren.O
描述The European School of Oncology came into existence to respond to a need for informa- tion, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was. considered necessary. Firstly, the teaching of oncology requires a rigorously multidisciplinary approach which is difficult for the Univer- sities to put into practice since their system is mainly disciplinary orientated. Secondly, the rate of technological development that impinges on the diagnosis and treatment of cancer has been so rapid that it is not an easy task for medical faculties to adapt their curricula flexibly. With its residential courses for organ pathologies and the seminars on new techniques (laser, monoclonal antibodies, imaging techniques etc.) or on the principal therapeutic controversies (conservative or mutilating surgery, primary or adjuvant chemotherapy, radiotherapy alone or integrated), it is the ambition of the European School of Oncology to fill a cultural and scientific gap and, thereby, create a bridge between the University and Industry and between these two and daily medical practice. One of the more recent initiatives of ESO has
出版日期Conference proceedings 1990
關鍵詞Hormonrezeptoren; Ovarsuppression; breast cancer; cancer; carcinogenesis; cell; chemotherapy; genetics; horm
版次1
doihttps://doi.org/10.1007/978-3-642-75948-2
isbn_softcover978-3-642-75950-5
isbn_ebook978-3-642-75948-2
copyrightSpringer-Verlag Berlin Heidelberg 1990
The information of publication is updating

書目名稱Endocrine Therapy of Breast Cancer IV影響因子(影響力)




書目名稱Endocrine Therapy of Breast Cancer IV影響因子(影響力)學科排名




書目名稱Endocrine Therapy of Breast Cancer IV網(wǎng)絡公開度




書目名稱Endocrine Therapy of Breast Cancer IV網(wǎng)絡公開度學科排名




書目名稱Endocrine Therapy of Breast Cancer IV被引頻次




書目名稱Endocrine Therapy of Breast Cancer IV被引頻次學科排名




書目名稱Endocrine Therapy of Breast Cancer IV年度引用




書目名稱Endocrine Therapy of Breast Cancer IV年度引用學科排名




書目名稱Endocrine Therapy of Breast Cancer IV讀者反饋




書目名稱Endocrine Therapy of Breast Cancer IV讀者反饋學科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-21 23:32:28 | 只看該作者
osis and treatment of cancer. There are two main reasons why such an initiative was. considered necessary. Firstly, the teaching of oncology requires a rigorously multidisciplinary approach which is difficult for the Univer- sities to put into practice since their system is mainly disciplinary orien
板凳
發(fā)表于 2025-3-22 04:24:07 | 只看該作者
地板
發(fā)表于 2025-3-22 07:44:15 | 只看該作者
Reproductive Diversity of Plants A remarkable feature of treatment with tamoxifen is the low incidence of side effects [1,3]. These clinical observations and the large body of evidence from the laboratory [6,7] have focussed clinical attention on long-term, or indefinite (treatment until relapse), adjuvant tamoxifen therapy [5,8–10].
5#
發(fā)表于 2025-3-22 12:40:48 | 只看該作者
Floral Morphology and Sexuality,ls indicate that it is as effective as older treatments, for example, oe- strogens [2], but has fewer side effects. In premenopausal women, treatment with tamoxifen is equivalent in effectiveness to oophorectomy [3].
6#
發(fā)表于 2025-3-22 13:09:59 | 只看該作者
Role of Oestrogen and Progestin in Human Mammary Carcinogenesis,cally-derived risk factors such as the protective effect of ovariectomy and increased risk of breast cancer in young women given diethylstilboestrol to prevent abortion [1,2]; and (c) the mitogenic effects of oestrogens on established breast cancer cell lines [5,6] and efficacy of antioestrogens in treating established breast cancer [7].
7#
發(fā)表于 2025-3-22 19:28:20 | 只看該作者
8#
發(fā)表于 2025-3-22 22:16:02 | 只看該作者
Tamoxifen as an Agonist for Metastatic Breast Cancer,ls indicate that it is as effective as older treatments, for example, oe- strogens [2], but has fewer side effects. In premenopausal women, treatment with tamoxifen is equivalent in effectiveness to oophorectomy [3].
9#
發(fā)表于 2025-3-23 01:26:19 | 只看該作者
10#
發(fā)表于 2025-3-23 06:41:27 | 只看該作者
https://doi.org/10.1007/978-1-4612-2866-0DNA ploidy, oncogenes, growth factor receptors, and some glycoproteins) are used for making therapeutic decisions [2]. At present, more than 60 prognostic parameters have been reported and can be classified into 4 main groups: patient characteristics, blood parameters, tumour characteristics and response to therapy (Table 2).
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 11:42
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
聂拉木县| 枞阳县| 天全县| 凤凰县| 合江县| 丰城市| 夏津县| 贵港市| 札达县| 阆中市| 资阳市| 修武县| 固镇县| 定兴县| 遵义县| 遂昌县| 汪清县| 中宁县| 贵州省| 绍兴市| 兴海县| 宝山区| 彭水| 灌阳县| 西乌珠穆沁旗| 长垣县| 贡山| 新昌县| 罗江县| 安国市| 莱阳市| 贞丰县| 温泉县| 苏尼特左旗| 无极县| 沿河| 望都县| 浑源县| 绍兴市| 太仓市| 台州市|